286 related articles for article (PubMed ID: 25131761)
1. Carcinogenic mechanisms of endometrial cancer: involvement of genetics and epigenetics.
Banno K; Yanokura M; Iida M; Masuda K; Aoki D
J Obstet Gynaecol Res; 2014 Aug; 40(8):1957-67. PubMed ID: 25131761
[TBL] [Abstract][Full Text] [Related]
2. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
3. New molecular aspects of endometrial carcinoma.
Nachajova M; Mersakova S; Sivakova J; Krivus S; Szepe P; Hatok J; Adamkov M
Neuro Endocrinol Lett; 2015 Dec; 36(7):638-43. PubMed ID: 26859584
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
5. Epigenetics and genetics in endometrial cancer: new carcinogenic mechanisms and relationship with clinical practice.
Banno K; Kisu I; Yanokura M; Masuda K; Ueki A; Kobayashi Y; Susumu N; Aoki D
Epigenomics; 2012 Apr; 4(2):147-62. PubMed ID: 22449187
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic DNA hypermethylation: clinical applications in endometrial cancer (Review).
Muraki Y; Banno K; Yanokura M; Kobayashi Y; Kawaguchi M; Nomura H; Hirasawa A; Susumu N; Aoki D
Oncol Rep; 2009 Nov; 22(5):967-72. PubMed ID: 19787208
[TBL] [Abstract][Full Text] [Related]
7. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer.
Tsuruta T; Kozaki K; Uesugi A; Furuta M; Hirasawa A; Imoto I; Susumu N; Aoki D; Inazawa J
Cancer Res; 2011 Oct; 71(20):6450-62. PubMed ID: 21868754
[TBL] [Abstract][Full Text] [Related]
8. Molecular carcinogenesis of endometrial cancer.
Liu FS
Taiwan J Obstet Gynecol; 2007 Mar; 46(1):26-32. PubMed ID: 17389185
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic fingerprint in endometrial carcinogenesis: the hypothesis of a uterine field cancerization.
Di Domenico M; Santoro A; Ricciardi C; Iaccarino M; Iaccarino S; Freda M; Feola A; Sanguedolce F; Losito S; Pasquali D; Di Spiezio Sardo A; Bifulco G; Nappi C; Bufo P; Guida M; De Rosa G; Abbruzzese A; Caraglia M; Pannone G
Cancer Biol Ther; 2011 Sep; 12(5):447-57. PubMed ID: 21709441
[TBL] [Abstract][Full Text] [Related]
10. Relationship of the aberrant DNA hypermethylation of cancer-related genes with carcinogenesis of endometrial cancer.
Banno K; Yanokura M; Susumu N; Kawaguchi M; Hirao N; Hirasawa A; Tsukazaki K; Aoki D
Oncol Rep; 2006 Dec; 16(6):1189-96. PubMed ID: 17089036
[TBL] [Abstract][Full Text] [Related]
11. [MICROSATELLITE INSTABILITY IN ENDOMETRIAL CANCER].
Stoyanov S; Aleksandrova E; Ivanova K; Ignatova M; Gulubova M
Akush Ginekol (Sofiia); 2015; 54(7):31-5. PubMed ID: 27025106
[TBL] [Abstract][Full Text] [Related]
12. High frequency of RASSF1A and RARb2 gene promoter methylation in morphologically normal endometrium adjacent to endometrioid adenocarcinoma.
Arafa M; Kridelka F; Mathias V; Vanbellinghen JF; Renard I; Foidart JM; Boniver J; Delvenne P
Histopathology; 2008 Nov; 53(5):525-32. PubMed ID: 18783461
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of endometrial tumorigenesis: importance of complex hyperplasia regardless of atypia.
Nieminen TT; Gylling A; Abdel-Rahman WM; Nuorva K; Aarnio M; Renkonen-Sinisalo L; Järvinen HJ; Mecklin JP; Bützow R; Peltomäki P
Clin Cancer Res; 2009 Sep; 15(18):5772-83. PubMed ID: 19723644
[TBL] [Abstract][Full Text] [Related]
14. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics.
Imai K; Yamamoto H
Carcinogenesis; 2008 Apr; 29(4):673-80. PubMed ID: 17942460
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
[TBL] [Abstract][Full Text] [Related]
16. Novel molecular profiles of endometrial cancer-new light through old windows.
Doll A; Abal M; Rigau M; Monge M; Gonzalez M; Demajo S; Colás E; Llauradó M; Alazzouzi H; Planagumá J; Lohmann MA; Garcia J; Castellvi S; Ramon y Cajal J; Gil-Moreno A; Xercavins J; Alameda F; Reventós J
J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):221-9. PubMed ID: 18061438
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation and expression of sprouty 2 in endometrial carcinoma.
Velasco A; Pallares J; Santacana M; Gatius S; Fernandez M; Domingo M; Valls J; Yeramian A; Encinas M; Dolcet X; Matias-Guiu X
Hum Pathol; 2011 Feb; 42(2):185-93. PubMed ID: 21111454
[TBL] [Abstract][Full Text] [Related]
18. Endometrial Cancer and Hypermethylation: Regulation of DNA and MicroRNA by Epigenetics.
Banno K; Kisu I; Yanokura M; Masuda K; Kobayashi Y; Ueki A; Tsuji K; Yamagami W; Nomura H; Susumu N; Aoki D
Biochem Res Int; 2012; 2012():738274. PubMed ID: 22548175
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of miR-203 in endometrial carcinomas.
Huang YW; Kuo CT; Chen JH; Goodfellow PJ; Huang TH; Rader JS; Uyar DS
Gynecol Oncol; 2014 May; 133(2):340-5. PubMed ID: 24530564
[TBL] [Abstract][Full Text] [Related]
20. [Dualistic model of molecular pathogenesis in endometrial carcinoma].
Lax SF
Zentralbl Gynakol; 2002 Jan; 124(1):10-6. PubMed ID: 11873308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
